Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, age 18 years or older at the time of signing informed consent
Body mass index (BMI) equal to or above 30.0 kg/m\^2 or equal to or above 27.0 kg/m\^2 with the presence of at least one of the following weight-related comorbidities (treated or untreated): hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease
History of at least one self-reported unsuccessful dietary effort to lose body weight
You may not be if
HbA1c equal to or above 48 mmol/mol (6.5%) as measured by the central laboratory at screening
History of type 1 or type 2 diabetes mellitus
A self-reported change in body weight of more than 5 kg (11 lbs) within 90 days before screening irrespective of medical records
Clareo Health | Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
